Skip to content

Post-transplantation monitoring

Screening for healthy lives

Close monitoring with chimerism testing allows doctors to track engraftment and rejection in stem cell transplant patients and quickly detect any signs of relapse or lingering disease.

Get in touch

IM-2022-chimerism_1

“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the management costs for transplant patients.”

Dr. Dan Hauzenberger MD, PhD, Karolinska University Hospital, Stockholm, Sweden

Knowledge is power

Ignorance should never be a cause of relapse in stem cell transplant patients. Post-transplant chimerism monitoring enables close evaluation of donor engraftment, rapid detection of graft rejection, and measurable/minimal residual disease.

Post-transplant monitoring using sensitive diagnostic tests offers invaluable insight when evaluating patient recovery. Regular testing maximizes the potential for post-operative success and enhances the patient quality of life.

What’s our role?
We provide highly accurate and trusted chimerism test solutions that enable labs to quickly detect relapse and the potential presence of residual disease.

Our kits are custom-built to help physicians create the best conditions for successful patient outcomes and to streamline lab operations with a fast, smooth workflow.

IM-2022-Lab_2

Fast. Sensitive. Accurate.

Devyser’s single-protocol solutions offer fast, sensitive, and reliable chimerism measurement and monitoring in transplanted patients.

Our test kits use embedded software to perform rapid and precise measurements, making it easy to track a patient’s trends and detect relapse or micro chimerism at an early stage.

For lab users, this one-stop-shop approach saves valuable time, minimizes errors and maximizes productivity. Our tests are extremely accurate, with a standard deviation of 0.05 percent.

IM-2022-blood_drop

Insight and inspiration